Aug 10 (Reuters)-
D.Western Therapeutics Institute Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2023 Jun 30, 2022 Dec 31, 2023
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 187 mln 210 mln 400 mln
(-10.6 pct) (+4.2 pct) (-10.7 pct)
Operating loss 258 mln loss 132 mln loss 1.40
Recurring loss 254 mln loss 118 mln loss 1.41
Net loss 247 mln loss 110 mln loss 1.39
EPS loss 7.89 yen loss 3.76 yen loss 44.60 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - D.Western Therapeutics Institute Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4576.T